Overview

A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma

Status:
Recruiting

Trial end date:
2023-07-15

Target enrollment:

Participant gender:

Summary

This prospective, multi-center, open single-arm Phase II clinical trial is designed to investigate the efficacy and safety of intravenous chemotherapy combined with Conbercept intravitreal injection in the treatment of retinoblastoma.

Phase:

Phase 2

Details

Lead Sponsor:

Chengdu Kanghong Biotech Co., Ltd.

Collaborator:

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University